// App-Quantinova.ai

3417 : A Systematic Review Evaluating the Effects of Treatment Duration on Bleeding Due to Factor-specific Oral Anticoagulant Therapy

Researchers

Presenter

  • Natalie Chan

Principal Investigators

  • Chantal Li

  • Keith K. Lau

  • Anthony K.C. Chan

  • Howard H.W. Chan

Medical Centers

  • Thrombosis & Univeristy of Western Ontario, London, ON, Canada,

  • McMaster University, Hamilton, ON, Canada

  • Hamilton, ON, Canada

  • Department of Medicine - Division of Hematology and Thromboembolism, McMaster University, Hamilton, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute Coronary Syndromes

  • Deep vein thrombosis

  • Arrhythmia

  • Pulmonary embolism

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • betrixaban

  • Pradax

  • apixaban

  • Edoxaban

Outcome

  • N/A


Study Design

  • non inferiority

  • randomized

  • pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim